BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2178854)

  • 1. Influence of single and multiple doses of oral ranitidine on the gastric transit of an indigestible capsule in humans.
    Mojaverian P; Vlasses PH; Parker S; Warner C
    Clin Pharmacol Ther; 1990 Mar; 47(3):382-8. PubMed ID: 2178854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of dual radiotelemetric technique in studying drug-drug interaction between diclofenac sodium and ranitidine HCl in volunteers.
    Alioth C; Blum RA; D'Andrea DT; Kochak GM; Teng L; Ziehmer BA; Schentag JJ; Chan KK
    Pharm Res; 1993 Nov; 10(11):1688-92. PubMed ID: 8290486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained release theophylline preparation.
    Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD
    Arzneimittelforschung; 1991 Nov; 41(11):1154-9. PubMed ID: 1810260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained-release theophylline preparation].
    Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):561-8. PubMed ID: 9676345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of raising gastric pH with ranitidine on the absorption and elimination of theophylline from a sustained-release theophylline tablet.
    Betlach CJ; Straughn AB; Meyer MC; Bialer M; Vashi VI; Liebermann P; González MA
    Pharm Res; 1991 Dec; 8(12):1516-9. PubMed ID: 1808616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ranitidine and cimetidine on gastric emptying of a mixed meal in man.
    Corinaldesi R; Scarpignato C; Galassi A; Stanghellini V; Calamelli R; Bertaccini G; Barbara L
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):498-501. PubMed ID: 6094367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
    Šutalo S; Ruetten M; Hartnack S; Reusch CE; Kook PH
    J Vet Intern Med; 2015; 29(3):840-6. PubMed ID: 25966746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition.
    Mojaverian P; Ferguson RK; Vlasses PH; Rocci ML; Oren A; Fix JA; Caldwell LJ; Gardner C
    Gastroenterology; 1985 Aug; 89(2):392-7. PubMed ID: 3891497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of ranitidine and famotidine in healthy elderly subjects: a double-blind, placebo-controlled comparison.
    Bisson C; St-Laurent M; Michaud JT; LeBel M
    Pharmacotherapy; 1993; 13(1):3-9. PubMed ID: 8437966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sodium acid pyrophosphate on ranitidine bioavailability and gastrointestinal transit time.
    Koch KM; Parr AF; Tomlinson JJ; Sandefer EP; Digenis GA; Donn KH; Powell JR
    Pharm Res; 1993 Jul; 10(7):1027-30. PubMed ID: 8397394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
    Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
    Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of gastric pH with oral glutamic acid hydrochloride.
    Knapp MJ; Berardi RR; Dressman JB; Rider JM; Carver PL
    Clin Pharm; 1991 Nov; 10(11):866-9. PubMed ID: 1686581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
    Kakuda TN; Falcon RW
    Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal transit of a solid indigestible capsule as measured by radiotelemetry and dual gamma scintigraphy.
    Mojaverian P; Chan K; Desai A; John V
    Pharm Res; 1989 Aug; 6(8):719-24. PubMed ID: 2813265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral cimetidine and ranitidine on gastric pH and residual volume in children.
    Guay J; Santerre L; Gaudreault P; Goulet B; Dupuis C
    Anesthesiology; 1989 Oct; 71(4):547-9. PubMed ID: 2679238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil.
    Hughes GS; Heald DL; Barker KB; Patel RK; Spillers CR; Watts KC; Batts DH; Euler AR
    Clin Pharmacol Ther; 1989 Dec; 46(6):674-85. PubMed ID: 2557183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose-dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects.
    Boyce M; David O; Darwin K; Mitchell T; Johnston A; Warrington S
    Aliment Pharmacol Ther; 2012 Jul; 36(2):181-9. PubMed ID: 22607579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.